Elite Recruit LLC1d ago

The nutraceutical industry isn't facing a product shortage. It's facing a talent shortage.

https://substack.com/home/post/p-201274717

The companies pulling ahead are building stronger scientific teams, experienced commercial leadership, and executives who understand a fast evolving wellness market. Products can be copied. Great teams are much harder to replicate.

#Nutraceuticals #DietarySupplements #HealthWellness #Leadership #LifeSciences #BusinessGrowth

The Best Nutraceutical Recruitment Firm for Sales, R&D, and Executive Hiring

From dietary supplements and functional ingredients to sports nutrition and personalized wellness, companies are racing to innovate, expand market share, and meet increasing consumer demand.

Elite Recruit LLC
Show threadGenelife Clinical Research4d ago
@EUCommission Great to see this push for transparency extend to everyday food products. The same principle is reshaping the nutraceutical and supplement space too — EFSA's health claims framework has already rejected the majority of botanical health claims for lack of clinical substantiation, and the direction is unmistakable: claims need evidence, not just plausibility. #Transparency #EUCommission #Nutraceuticals #FoodLabelling #ClinicalEvidence
Genelife Clinical ResearchJun 11

On Monday we published a detailed guide for international nutraceutical companies conducting clinical studies in India.
The question we hear most from international sponsors considering India for the first time:
"Will the data actually be accepted by our regulator?"
The answer is yes — but the conditions matter more than most sponsors realize before they start.

#Nutraceuticals #ClinicalResearch #India #CRO #FDA #EMA #TGA #DietarySupplements #InternationalClinicalTrials

https://genelifecr.blogspot.com/2026/06/conducting-nutraceutical-clinical.html

Conducting Nutraceutical Clinical Trials in India for International Regulatory Submissions: What Sponsors Need to Know

Nutraceutical clinical trials in India for FDA, EMA, and global regulatory submissions by Genelife Clinical Research.

Genelife Clinical ResearchJun 8

This article explains what international regulatory acceptability actually requires — and what to look for in a CRO partner that can deliver it.

#Nutraceuticals #ClinicalTrials #India #CRO #FDA #EMA #InternationalResearch #DietarySupplements

https://genelifecr.blogspot.com/2026/06/conducting-nutraceutical-clinical.html

Conducting Nutraceutical Clinical Trials in India for International Regulatory Submissions: What Sponsors Need to Know

Nutraceutical clinical trials in India for FDA, EMA, and global regulatory submissions by Genelife Clinical Research.

Genelife Clinical ResearchJun 4

The global regulatory direction for nutraceuticals is clear: prove it clinically, or lose the claim.

The problem: clinical trials in the US and EU are expensive enough that the ROI is genuinely difficult.

The solution more international nutraceutical companies are finding: conduct the study in India.

#Nutraceuticals #ClinicalTrials #India #CRO #FDA #EMA #DietarySupplements #EvidenceBased
https://genelifecr.blogspot.com/2026/05/the-evidence-gap-in-nutraceuticals-why.html

The Evidence Gap in Nutraceuticals: Why International Companies Are Turning to India to Close It

India is a preferred destination for nutraceutical evidence generation through clinical studies, RWE and cost-effective research capabilities.

Genelife Clinical ResearchJun 1

The era of marketing on plausibility and tradition alone is ending. Clinical evidence — rigorous, human, controlled — is becoming the price of credible market positioning.
The question for international nutraceutical companies isn't whether to generate that evidence. It's how to do it at a cost and speed that makes commercial sense.
#Nutraceuticals #ClinicalResearch #DietarySupplements #India #CRO #EvidenceBased #FDA #EMA #TGA

https://genelifecr.blogspot.com/2026/05/the-evidence-gap-in-nutraceuticals-why.html

The Evidence Gap in Nutraceuticals: Why International Companies Are Turning to India to Close It

India is a preferred destination for nutraceutical evidence generation through clinical studies, RWE and cost-effective research capabilities.

Genelife Clinical ResearchJun 1

Monday's article breaks down the evidence gap, why it's closing, and why India is where international nutraceutical companies are choosing to close it.

#Nutraceuticals #ClinicalResearch #DietarySupplements #India #CRO #EvidenceBased #FDA #EMA #TGA

https://genelifecr.blogspot.com/2026/05/the-evidence-gap-in-nutraceuticals-why.html

The Evidence Gap in Nutraceuticals: Why International Companies Are Turning to India to Close It

India is a preferred destination for nutraceutical evidence generation through clinical studies, RWE and cost-effective research capabilities.

Elite Recruit LLCMay 29
https://medium.com/@elite-recruit/what-wellness-brands-are-prioritizing-differently-in-2026-cdf26cecf145
Wellness brands growing in 2026 are not chasing trends anymore.
They are building trust through science, quality, innovation, and real consumer value.
#WellnessIndustry #Nutraceuticals #HealthInnovation #WellnessBrands #SupplementIndustry #ConsumerHealth #Manufacturing
What Wellness Brands Are Prioritizing Differently In 2026

The wellness industry in 2026 is moving through a major transformation. Consumers are becoming more aware of what they buy, how products…

Medium
aniketsandujaMay 24
𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝗶𝗻𝗴𝗿𝗲𝗱𝗶𝗲𝗻𝘁 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 𝗶𝘀 𝗼𝗽𝗲𝗻𝗶𝗻𝗴 𝗻𝗲𝘄 𝗼𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝗶𝗲𝘀 𝗮𝗰𝗿𝗼𝘀𝘀 𝗔𝘀𝗶𝗮 𝗣𝗮𝗰𝗶𝗳𝗶𝗰 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗺𝗮𝗿𝗸𝗲𝘁𝘀!
The 𝗔𝘀𝗶𝗮 𝗣𝗮𝗰𝗶𝗳𝗶𝗰 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹 𝗚𝗿𝗮𝗱𝗲 𝗥𝗶𝗰𝗲 𝗦𝘁𝗮𝗿𝗰𝗵 𝗠𝗮𝗿𝗸𝗲𝘁 is expanding due to rising demand for clean label excipients, drug formulation advancements, and growth in nutraceutical applications.
𝗥𝗲𝗮𝗱 𝗺𝗼𝗿𝗲: https://www.kenresearch.com/industry-reports/asia-pacific-pharmaceutical-grade-rice-starch-market?utm_source=Social+sharing+&utm_medium=Mastodon&utm_campaign=Aniket
#Pharmaceuticals #Healthcare #AsiaPacific #Nutraceuticals
Asia Pacific Pharmaceutical Grade Rice Starch Market, Share, Major Players and Outlook to 2030

Unlock data-backed intelligence on Asia Pacific Pharmaceutical Grade Rice Starch Market size at USD 500 million in 2023, showcasing industry growth driven by key players and strategic insights.

YavoApr 25

Think about it: Just as COVID-19 depletes zinc leading to impaired sense of smell, so it depletes L-Arginine leading to a group of persistent symptoms, known as 'long covid.'

https://pmc.ncbi.nlm.nih.gov/articles/PMC9738241/

#covid #Covid19 #SarsCovid19 #LongCovid #Biohacking #Nutraceuticals

Checking your browser - reCAPTCHA